Demyelinating disease and polyvalent human papilloma virus vaccination

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 11, 2011, Pages 1296-1298

  Chang, Jason ^a   Campagnolo, Denise ^a   Vollmer, Timothy L ^b   Bomprezzi, Roberto ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NATALIZUMAB; WART VIRUS VACCINE;

ADULT; BACKACHE; CASE REPORT; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOOT; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; DEMYELINATING DISEASES; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; TIME FACTORS; VACCINATION;

EID: 80053627798     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.214924     Document Type: Letter

References (5)

1. Siegrist CA, Lewis EM, Eskola J, et al. Human papilloma virus immunization in adolescent and adults. Pediatr Infect Dis J 2007;26:979-84.
2. Sutton I, Lahoria R, Tan I, et al. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009;15:116-19.
3. Wildemann B, Jarius S, Hartmann M, et al. Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology 2009;72:2132-3.
4. Douglas RJ. Quadrivalent HPV vaccination reactionsdmore hype than harm. Aust Fam Physician 2009;38:139-42.
5. Jeurissen S, Makar A. Epidemiological and economic impact of human papillomavirus vaccines. Int J Gynelogical Cancer 2009;19:761-71.